Thangaraj, J. L., Lopez, E., Tharp, K., Kaufman, D. (2025). Engineered iPSC-derived NK cells targeting the SIGLEC7-glyco-immune checkpoint improves anti-tumor activity in solid cancers. Blood. https://doi.org/10.1182/blood-2025-5913